Catalyst Pharmaceuticals to Participate in the BofA
Exploring the Healthcare Landscape: Catalyst Pharmaceuticals at the BofA Securities Health Care Conference 2025 Catalyst Pharmaceuticals, Inc., a foremost player in the biopharmaceutical sector, stands at the forefront of innovation with its focus on rare and hard-to-treat diseases. Recently, the company announced the participation of its President and CEO, Richard J. Daly, and key management … Read more